Loading…

Carbene-catalyzed kinetic resolution of bispirooxindoles: selective lactam amidation and access to challenging chiral scaffolds

Despite kinetic resolution (KR) via N-heterocyclic carbene (NHC)-catalyzed acylation minimizing any competitive racemic background reactions, the KR of NHC-activated lactam amidation is mostly uninvestigated. Enantioenriched bispirooxindoles bearing multichiral quaternary stereocenters have importan...

Full description

Saved in:
Bibliographic Details
Published in:Organic chemistry frontiers an international journal of organic chemistry 2023-02, Vol.10 (5), p.1230-1236
Main Authors: Pu, Yiru, Zuo, Yi, Ling, Jie, Li, Meimei, Huang, Hui, Zhang, Chaozheng, Yang, Jirui, Deng, Yun, Wang, Maolin, Lu, Jun
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite kinetic resolution (KR) via N-heterocyclic carbene (NHC)-catalyzed acylation minimizing any competitive racemic background reactions, the KR of NHC-activated lactam amidation is mostly uninvestigated. Enantioenriched bispirooxindoles bearing multichiral quaternary stereocenters have important applications in chemical and medical fields, but their enantioselective synthesis remains extremely challenging. Described herein is an unprecedented strategy for realizing NHC-catalyzed atroposelective amidation of lactams on racemic bispirooxindoles with enals, providing high to excellent yields and stereoselectivities and superior KR performances (S-factor >500). Density functional theory calculations of the reaction mechanism and the origin of the enantioselectivity indicated steric repulsion between oxindole and trimethylphenyl to be responsible for the stereoselectivity. Given the utmost importance of chirality for bioactivity and the widespread presence of spirocyclic structures in pharmaceutical molecules, we expect that our reaction pattern results will significantly expand the applications of NHCs in KR and for future drug discovery purposes.
ISSN:2052-4110
2052-4110
DOI:10.1039/d2qo01724e